Showing 1721-1730 of 2237 results for "".
- FDA Approves South Korean Neurotoxin for Frown Lineshttps://modernaesthetics.com/news/fda-approves-south-korean-neurotoxin-for-frown-lines/2473751/The US Food and Drug Administration approved the neurotoxin, Letybo (letibotulinumtoxinA-wlbg), to treat moderate-to-severe glabellar lines in adults, Hugel Inc. announced last week. According to a press release, Hugel Inc. plans to accelerate its transition for approved medical use with
- Martha Stewart Discusses BOTOX for Platysma Bandshttps://modernaesthetics.com/news/martha-stewart-discusses-botox-for-platysma-bands/2473750/BOTOX Cosmetic’s platysma bands indication has a fan in Martha Stewart. The keynote speaker at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, said she visits her dermatologist “once every couple months.” Gesturing to her jaw and neck, Stewart said she ge
- Closing the Healthcare Gender Gap as a Key to Optimize Female Longevityhttps://modernaesthetics.com/news/closing-the-healthcare-gender-gap-as-a-key-to-optimize-female-longevity/2473748/"The story of women's struggle for equality belongs to no single feminist nor to any one organization but to the collective efforts of all who care about human rights." —Gloria Steinem The United Nations has declared the theme for this year’s International
- Skinbetter Science Launches BioRewind Skin Health Dietary Supplement to Combat Skin Glycationhttps://modernaesthetics.com/news/skinbetter-science-launches-biorewind-skin-health-dietary-supplement-to-combat-skin-glycation/2473747/Skinbetter science launched BioRewind, a skin health dietary supplement with a purpose of visibly improving skin quality by helping reduce advanced glycation endproducts (AGEs), on Monday. Glycation is a key contributor to skin aging and this supplement’s formula is clinically demonstrate
- Aesthetic Treatments Becoming More Popular Among Men, AAFPRS Data Showshttps://modernaesthetics.com/news/aesthetic-treatments-becoming-more-popular-among-men-aafprs-data-shows/2473744/While most patients for aesthetic treatments and procedures are women, men are beginning to embrace the industry, according to new data from the American Academy of Facial Plastic and Reconstructive Surgery. Men continue to surpass women when it comes to hair transplantation. Among AAFPRS
- Allergan Aesthetics Casting Breast Reconstruction, Augmentation Patients for Latest Campaignhttps://modernaesthetics.com/news/allergan-aesthetics-casting-breast-reconstruction-augmentation-patients-for-latest-campaign/2473743/Allergan Aesthetics wants to hear from patients who have experienced a Natrelle breast reconstruction or augmentation. The AbbVie company is searching for women to share their inspiring stories and be featured in an upcoming Allergan Aesthetics campaign. The campaign is an extension of th
- 2025 Octane Aesthetics Tech Forum: The Growth of Hair Panelhttps://modernaesthetics.com/news/the-growth-of-hair-2025-octane-aesthetics-tech-forum/2473741/The Growth of Hair panel at the 2025 Octane Aesthetics Tech Forum brought together leading experts in dermatology, pharmacology, and regenerative medicine to discuss exciting advancements in hair loss treatments and technologies. The panel included Ken Washenik, MD; Wajdie Ahmad, Co-Founder &
- FDA Approves New HA Gels From Evolushttps://modernaesthetics.com/news/fda-approves-new-ha-gels-from-evolus/2473740/The US Food and Drug Administration has approved Evolysse™ Form and Evolysse™ Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse™ collection, Evolus announced. These approvals mark Evolus’ entry into the United States HA dermal filler market and solidifies the com
- AMI Opens Three New US Training Centershttps://modernaesthetics.com/news/ami-opens-three-new-us-training-centers/2473739/Allergan Medical Institute (AMI) will open three new state-of-the-art training centers in the United States, according to an announcement from Allergan Aesthetics, an AbbVie company. AMI says its curriculum is designed to accelerate the science and art of aesthetics and, along with the com
- Utah Surgeon's LumipenPro Enlists Archetype to Pursue EU MDR Approvalhttps://modernaesthetics.com/news/utah-surgeons-lumipenpro-enlists-archetype-to-pursue-eu-mdr-approval/2473738/Medtech innovation management consultancy Archetype has been appointed to drive the European Medical Device Regulation (EU MDR) approval process for LumipenPro™, a medical illumination device designed to enhance precision and efficiency during aesthetic surgical procedures where visibility is res